NCT02911480View on ClinicalTrials.gov

Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

August 31, 2017

Conditions
Healthy Women of Child Bearing Potential
Interventions
DRUG

Oxytocin

Sponsors
All Listed Sponsors
lead

Oxytone Bioscience BV

INDUSTRY

NCT02911480 - Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin | Biotech Hunter | Biotech Hunter